Kodiak Sciences Inc. (KOD) stock
KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$96.80−3.93 (-3.90%)
Close on Nov 17, 2026Market cap $6.08BP/E –Yield –
Kodiak Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Kodiak Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$158.51M. For fiscal 2025 it was -$136.01M. The highest annual figure on record is -$16.05M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$136.01M | – |
| FY2024 | Dec 31, 2024 | -$117.32M | – |
| FY2023 | Dec 31, 2023 | -$154.18M | – |
| FY2022 | Dec 31, 2022 | -$206.46M | – |
| FY2021 | Dec 31, 2021 | -$182.27M | – |
| FY2020 | Dec 31, 2020 | -$83.43M | – |
| FY2019 | Dec 31, 2019 | -$39.15M | – |
| FY2018 | Dec 31, 2018 | -$29.03M | – |
| FY2017 | Dec 31, 2017 | -$17.66M | – |
| FY2016 | Dec 31, 2016 | -$16.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$46.24M | – |
| Q1 FY2026 | Mar 31, 2026 | -$40.01M | – |
| Q4 FY2025 | Dec 31, 2025 | -$39.38M | – |
| Q3 FY2025 | Sep 30, 2025 | -$32.88M | – |
| Q2 FY2025 | Jun 30, 2025 | -$34.67M | – |
| Q1 FY2025 | Mar 31, 2025 | -$29.08M | – |
| Q4 FY2024 | Dec 31, 2024 | -$30.07M | – |
| Q3 FY2024 | Sep 30, 2024 | -$21.16M | – |
| Q2 FY2024 | Jun 30, 2024 | -$26.49M | – |
| Q1 FY2024 | Mar 31, 2024 | -$39.60M | – |
| Q4 FY2023 | Dec 31, 2023 | -$32.24M | – |
| Q3 FY2023 | Sep 30, 2023 | -$32.76M | – |
| Q2 FY2023 | Jun 30, 2023 | -$41.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$47.22M | – |
| Q4 FY2022 | Dec 31, 2022 | -$55.08M | – |
| Q3 FY2022 | Sep 30, 2022 | -$53.09M | – |
| Q2 FY2022 | Jun 30, 2022 | -$55.14M | – |
| Q1 FY2022 | Mar 31, 2022 | -$43.16M | – |
| Q4 FY2021 | Dec 31, 2021 | -$59.04M | – |
| Q3 FY2021 | Sep 30, 2021 | -$51.95M | – |
| Q2 FY2021 | Jun 30, 2021 | -$36.66M | – |
| Q1 FY2021 | Mar 31, 2021 | -$34.63M | – |
| Q4 FY2020 | Dec 31, 2020 | -$27.02M | – |
| Q3 FY2020 | Sep 30, 2020 | -$24.57M | – |
| Q2 FY2020 | Jun 30, 2020 | -$13.91M | – |
| Q1 FY2020 | Mar 31, 2020 | -$17.93M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.29M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.70M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.95M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.21M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.34M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.98M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.45M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.26M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.90M | – |
See a number that looks wrong?